The effectiveness of the mumps component of the MMR vaccine: A case control study

Vaccine

Volumn 23, Issue 31, 2005, Pages 4070-4074

  Harling, Richard ^a   White, Joanne M ^a   Ramsay, Mary E ^a   Macsween, Karen F ^b   Van Den Bosch, Corry ^c  

^a CDSC   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c East London and the City Health Authority   (United Kingdom)

Author keywords

Case control; Mumps; Vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MUMPS VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG DOSE; MUMPS; PRIORITY JOURNAL; SINGLE DRUG DOSE; VACCINATION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LONDON; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS;

EID: 18844418820     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.10.020     Document Type: Article

References (31)

1. C.A. Van den Bosch, T. Cohen, and L. Walters Mumps outbreak confined to a religious community Eurosurveillance 5 2000 58 60
2. Health Protection Agency. Mumps Notifications, by Sex 1989-2003. http://www.hpa.org.uk/infections/topics_az/mumps/data_not_sex.htm.
3. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 1998;47(RR-8): 1-57.
4. M. Bottiger, B. Christenson, J. Taranger, and M. Bergman Swedish experience of two dose vaccination programme aimed at eliminating measles, mumps and rubella in Sweden BMJ 295 1987 1264 1267
5. H. Peltola, O.P. Heinonen, M. Valle, M. Paunio, M. Virtanen, and V. Karanko The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program NEJM 331 1994 1397 1402
6. E.A. Reaney, V.K. Tohani, M.J. Devine, R.D. Smithson, and B. Smyth Mumps outbreak among young people in Northern Ireland Commun Dis Public Health 4 2001 311 315
7. R.N. Pugh, B. Akinosi, S. Pooransingh, J. Kumar, S. Grant, and E. Livesley An outbreak of mumps in the metropolitan area of Walsall, UK Int J Infect Dis 6 2002 283 287
8. Immunisation against infectious disease. The Green Book. Department of Health; 1996.
9. R.E. Weibel, J. Stokes, E.B. Buynak, J.E. Whitman Jr., and M.R. Hilleman Live attenuated mumps virus vaccine: clinical and serological aspects in a field trial NEJM 276 1967 245 251
10. W.C. Sugg, J.A. Finger, R.H. Levine, and J.S. Pagano Field evaluation of live virus mumps vaccine J Pediatr 72 1968 461 466
11. P.A. Brunell, A. Brickman, and S. Steinberg Evaluation of a live attenuated mumps vaccine (Jeryl Lynn) Am J Dis Child 118 1969 435 440
12. T. Vesikari, F.E. Andre, E. Simoen, G. Florent, E.L. Ala-Laurila, and A. Heikkinen Evaluation in young children of the Urabe am 9-strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain Acta Paediatr Scand 72 1983 37 40
13. M.R. Hilleman, E.B. Buynak, R.E. Weibel, J. Stokes Jr., and J.E. Whitman Jr. Live, attenuated mumps virus vaccine: protective efficacy as measured in a field evaluation NEJM 276 1967 252 258
14. CDC. Mumps in an elementary school. MMWR 1973;22:185-6.
15. J.E. Lewis, M.A. Chernesky, M.L. Rawls, and W.E. Rawls Epidemic of mumps in a partially immune population CMAJ 121 1979 751 754
16. K.M. Sullivan, T.J. Halpin, J.S. Marks, and R. Kim-Farley Effectiveness of mumps vaccine in a school outbreak Am J Dis Child 139 1985 909 912
17. R. Kim-Farley, S. Bart, H. Stetler, W. Orenstein, K. Bart, and K. Sullivan Clinical mumps vaccine efficacy Am J Epidemiol 121 1985 593 597
18. CDC. Mumps outbreak. MMWR 1984;33:421-30.
19. M. Wharton, S. Cochi, and R.H. Hutcheson A large outbreak of mumps in the postvaccine era J Infect Dis 158 1988 1253 1260
20. B.S. Hersh, Fine PEM, and W.K. Kent Mumps outbreak in a highly vaccinated population J Pediatr 119 1991 187 193
21. J.E. Cheek, R. Baron, and H. Atlas Mumps outbreak in a highly vaccinated school population Arch Pediatr Adolesc Med 149 1995 774 778
22. P.A. Briss, L.J. Fehrs, R.A. Parker, P.F. Wright, E.C. Sannella, and R.H. Hutcheson Sustained transmission of mumps in highly vaccinated population: assessment of primary vaccine failure and waning immunity J Infect Dis 169 1994 77 82
23. E. Chamot, L. Toscani, P. Egger, D. Germann, and C. Bourquin Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton Revue d'Epidemiologie et de Sante Publique 46 1998 100 107
24. D. Germann, A. Strohle, K. Eggenberger, C. Steiner, and L. Matter An outbreak of mumps in a population partially vaccinated with the Rubini strain Scand J Infect Dis 28 1996 235 238
25. F. De la Hoz, K. Zeitler, C. Gracia Colmenero, M.J. Puchades Belenguer, C. Verde Lopez, and J.L. Carpintero Redondo Mumps epidemic in the health area of Toledo with immunisation intervention. Estimation of vaccine efficacy Medicina Clinica 108 1997 175 179
26. L. Toscani, M. Batou, P. Bouvier, and Al. Schlaepfer Comparison of the efficacy of various strains of mumps vaccine: a school, survey Sozial und Praventivmedizin 41 1996 341 347
27. M. Schlegal, J.J. Osterwalder, L. Galeazzi, and P.L. Vernazza Comparative efficacy of three mumps vaccines in eastern Switzerland: cohort study BMJ 319 1999 352 353
28. B. Lopez Hernandez, R.M. Martin Velez, and R. Garcia An epidemic of mumps: a study of vaccine efficacy Atencion Primaria 25 2000 148 152
29. J. Buxton, C. Craig, P. Daly, M. Bigham, A. Bell, and M. Fyfe An outbreak of mumps among young people in Vancouver, British Columbia, associated with rave parties Can J Public Health 90 1999 160 163
30. W.A. Orenstein, R.H. Bernier, and A.R. Hinman Assessing vaccine efficacy in the field Epidemiol Rev 10 1988 212 241
31. C. Hani Barag What's not in a name. The accuracy of using names to ascribe religious and geographical origin in a British population J Epidemiol Commun Health 52 1998 336 337